BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20824855)

  • 1. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.
    Ismail SI; Bain C; Hagen S
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007063. PubMed ID: 20824855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women.
    Taithongchai A; Johnson EE; Ismail SI; Barron-Millar E; Kernohan A; Thakar R
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD014592. PubMed ID: 37431855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen therapy for urinary incontinence in post-menopausal women.
    Cody JD; Jacobs ML; Richardson K; Moehrer B; Hextall A
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD001405. PubMed ID: 23076892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
    Nastri CO; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Martins WP
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009672. PubMed ID: 23737033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective oestrogen receptor modulators (SERMs) for endometriosis.
    van Hoesel MH; Chen YL; Zheng A; Wan Q; Mourad SM
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011169. PubMed ID: 33973648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative prevention and management of pelvic organ prolapse in women.
    Hagen S; Stark D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD003882. PubMed ID: 22161382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative interventions in pelvic organ prolapse surgery.
    Haya N; Feiner B; Baessler K; Christmann-Schmid C; Maher C
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013105. PubMed ID: 30121957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local oestrogen for vaginal atrophy in postmenopausal women.
    Lethaby A; Ayeleke RO; Roberts H
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen.
    Vardy MD; Lindsay R; Scotti RJ; Mikhail M; Richart RM; Nieves J; Zion M; Cosman F
    Am J Obstet Gynecol; 2003 Jul; 189(1):81-8. PubMed ID: 12861143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen therapy for urinary incontinence in post-menopausal women.
    Cody JD; Richardson K; Moehrer B; Hextall A; Glazener CM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001405. PubMed ID: 19821277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative management of pelvic organ prolapse in women.
    Hagen S; Stark D; Maher C; Adams E
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003882. PubMed ID: 17054190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.
    Perrotta C; Aznar M; Mejia R; Albert X; Ng CW
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre study.
    Marschalek ML; Bodner K; Kimberger O; Zehetmayer S; Morgenbesser R; Dietrich W; Obruca C; Husslein H; Umek W; Koelbl H; Bodner-Adler B
    BJOG; 2021 Dec; 128(13):2200-2208. PubMed ID: 34464489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of pelvic organ prolapse in women.
    Maher C; Feiner B; Baessler K; Schmid C
    Cochrane Database Syst Rev; 2013 Apr; (4):CD004014. PubMed ID: 23633316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of pelvic organ prolapse in women: a short version Cochrane review.
    Maher C; Baessler K; Glazener CM; Adams EJ; Hagen S
    Neurourol Urodyn; 2008; 27(1):3-12. PubMed ID: 18092333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of pelvic organ prolapse in women.
    Maher C; Baessler K; Glazener CM; Adams EJ; Hagen S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004014. PubMed ID: 17636742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy.
    Pinkerton JV; Stanczyk FZ
    Menopause; 2014 Mar; 21(3):309-19. PubMed ID: 23777900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.